BamSEC and AlphaSense Join Forces
Learn More

Lineage Cell Therapeutics, Inc. – Indentures

NYSE American: LCTX    
Share price (4/24/26): $1.55    
Market cap (4/24/26): $386 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.3
from S-3 41 pages Lineage Cell Therapeutics, Inc., Issuer and [Trustee], Trustee Indenture Dated as of [●], 20__ Debt Securities
12/34/56
EX-4.03(C)
from 10-K 19 pages Common Share Purchase Warrant Lineage Cell Therapeutics, Inc
12/34/56
EX-4.02
from 10-K 3 pages Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.1
from 8-K 19 pages Common Share Purchase Warrant Lineage Cell Therapeutics, Inc
12/34/56
EX-4.3
from 8-K 21 pages Placement Agent Common Share Purchase Warrant Lineage Cell Therapeutics, Inc
12/34/56
EX-4.2
from 8-K 18 pages Common Share Purchase Warrant Lineage Cell Therapeutics, Inc
12/34/56
EX-4.1
from 8-K 21 pages Common Share Purchase Warrant Lineage Cell Therapeutics, Inc
12/34/56
EX-4.3
from S-3 53 pages Lineage Cell Therapeutics, Inc., Issuer and [Trustee], Trustee Indenture Dated as of [●], 20__ Debt Securities
12/34/56
EX-4.7
from S-3 19 pages Lineage Cell Therapeutics, Inc. and , as Warrant Agent Form of Debt Securities Warrant Agreement Dated as of Lineage Cell Therapeutics, Inc. Form of Debt Securities Warrant Agreement
12/34/56
EX-4.6
from S-3 21 pages Lineage Cell Therapeutics, Inc. and , as Warrant Agent Form of Preferred Share Warrant Agreement Dated as of Lineage Cell Therapeutics, Inc. Form of Preferred Share Warrant Agreement
12/34/56
EX-4.5
from S-3 22 pages Lineage Cell Therapeutics, Inc. and , as Warrant Agent Form of Common Share Warrant Agreement Dated as of Lineage Cell Therapeutics, Inc. Form of Common Share Warrant Agreement
12/34/56
EX-4.3
from S-3 53 pages Lineage Cell Therapeutics, Inc., Issuer and [Trustee], Trustee Indenture Dated as of [●], 20__ Debt Securities
12/34/56
EX-4.2
from 10-K 2 pages Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.7
from S-3 19 pages Lineage Cell Therapeutics, Inc. and , as Warrant Agent Form of Debt Securities Warrant Agreement Dated as of Lineage Cell Therapeutics, Inc. Form of Debt Securities Warrant Agreement
12/34/56
EX-4.6
from S-3 21 pages Lineage Cell Therapeutics, Inc. and , as Warrant Agent Form of Preferred Share Warrant Agreement Dated as of Lineage Cell Therapeutics, Inc. Form of Preferred Share Warrant Agreement
12/34/56
EX-4.5
from S-3 22 pages Lineage Cell Therapeutics, Inc. and , as Warrant Agent Form of Common Share Warrant Agreement Dated as of Lineage Cell Therapeutics, Inc. Form of Common Share Warrant Agreement
12/34/56
EX-4.3
from S-3 53 pages Lineage Cell Therapeutics, Inc., Issuer and [Trustee], Trustee Indenture Dated as of [●], 20__ Debt Securities
12/34/56
EX-4.2
from 10-K 2 pages Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.2
from S-8 2 pages 2017 Amendment to Biotime, Inc. 2012 Equity Incentive Plan
12/34/56
EX-4.4
from S-3 45 pages Biotime, Inc. Issuer and as Trustee Indenture Dated as of , 20 Debt Securities
12/34/56